ATE533768T1 - Imidazol-derivate, ihre herstellung und ihre verwendung - Google Patents

Imidazol-derivate, ihre herstellung und ihre verwendung

Info

Publication number
ATE533768T1
ATE533768T1 AT05077705T AT05077705T ATE533768T1 AT E533768 T1 ATE533768 T1 AT E533768T1 AT 05077705 T AT05077705 T AT 05077705T AT 05077705 T AT05077705 T AT 05077705T AT E533768 T1 ATE533768 T1 AT E533768T1
Authority
AT
Austria
Prior art keywords
production
imidazole derivatives
imidazole
derivatives
Prior art date
Application number
AT05077705T
Other languages
English (en)
Inventor
Akihiro Tasaka
Takenori Hitaka
Nobuyuki Matsunaga
Masami Kusaka
Mari Adachi
Isao Aoki
Akio Ojida
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE533768T1 publication Critical patent/ATE533768T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT05077705T 2000-11-17 2001-11-16 Imidazol-derivate, ihre herstellung und ihre verwendung ATE533768T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000351780 2000-11-17
JP2001247618 2001-08-17
JP2001336880 2001-11-01

Publications (1)

Publication Number Publication Date
ATE533768T1 true ATE533768T1 (de) 2011-12-15

Family

ID=27345219

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01982800T ATE327237T1 (de) 2000-11-17 2001-11-16 Imidazol derivate, ihre herstellung und ihre verwendung
AT05077705T ATE533768T1 (de) 2000-11-17 2001-11-16 Imidazol-derivate, ihre herstellung und ihre verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01982800T ATE327237T1 (de) 2000-11-17 2001-11-16 Imidazol derivate, ihre herstellung und ihre verwendung

Country Status (26)

Country Link
US (1) US7141598B2 (de)
EP (2) EP1334106B1 (de)
JP (2) JP3753971B2 (de)
KR (3) KR100725442B1 (de)
CN (3) CN1900079A (de)
AR (1) AR034854A1 (de)
AT (2) ATE327237T1 (de)
AU (3) AU2002214296C1 (de)
BR (1) BR0115306B1 (de)
CA (1) CA2429133C (de)
CY (1) CY1105423T1 (de)
DE (1) DE60119963T2 (de)
DK (1) DK1334106T3 (de)
ES (1) ES2260303T3 (de)
HU (1) HU229408B1 (de)
IL (2) IL155624A0 (de)
MX (1) MXPA03004347A (de)
MY (1) MY134929A (de)
NO (1) NO326366B1 (de)
NZ (1) NZ526387A (de)
PE (1) PE20020596A1 (de)
PL (1) PL204934B1 (de)
PT (1) PT1334106E (de)
SI (1) SI1334106T1 (de)
TW (1) TWI306099B (de)
WO (1) WO2002040484A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1471056B1 (de) * 2002-01-10 2012-07-11 Takeda Pharmaceutical Company Limited Verfahren zur herstellung einer kondensierten imidazolverbindung, reformatskyreagens in stabiler form und verfahren zu dessen herstellung
JP4745616B2 (ja) * 2003-02-26 2011-08-10 武田薬品工業株式会社 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法
WO2004075890A1 (ja) * 2003-02-26 2004-09-10 Takeda Pharmaceutical Company 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾ－ル誘導体の安定化方法
JP4837895B2 (ja) * 2003-03-17 2011-12-14 武田薬品工業株式会社 放出制御組成物
CA2519211A1 (en) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited Release control compositions
JP5070042B2 (ja) * 2004-05-03 2012-11-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドローゲン受容体モジュレーター（ｓａｒｍｓ）としての新規インドール化合物
US20080076784A1 (en) * 2004-05-28 2008-03-27 Peter Herold Bicyclic, Nitrogen-Containing Heterocycles and Aromatase Inhibitors
JP5159303B2 (ja) * 2005-03-03 2013-03-06 武田薬品工業株式会社 放出制御組成物
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
TW200804378A (en) * 2005-12-09 2008-01-16 Speedel Experimenta Ag Organic compounds
DE602007007734D1 (de) * 2006-02-10 2010-08-26 Janssen Pharmaceutica Nv Neue imidazolopyrazolderivate als selektive androgen-rezeptor-modulatoren
TW200804284A (en) * 2006-03-31 2008-01-16 Speedel Experimenta Ag Process for preparing 6,7-dihydro-5H-imidazo[1,5-a]pyridin-8-one
SG185930A1 (en) * 2007-10-29 2012-12-28 Takeda Pharmaceutical Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
PE20211639A1 (es) 2009-01-15 2021-08-24 Incyte Holdings Corp Procesos para preparar inhibidores de jak y compuestos intermediarios relacionado
AR083916A1 (es) * 2010-11-18 2013-04-10 Takeda Pharmaceutical Metodo para tratar el cancer de mama y cancer de ovarios
TW201244757A (en) 2011-04-01 2012-11-16 Takeda Pharmaceutical Solid preparation
BR112013030888A2 (pt) * 2011-06-15 2017-03-21 Takeda Pharmaceuticals Co método para produzir um composto.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
NZ221729A (en) 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
NZ224288A (en) 1987-04-22 1989-12-21 Merrell Dow Pharma 17b-(cyclopropylamino)androst-5-en-3b-ol and related compounds and methods using these for treatment of non-humans
US5057521A (en) * 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
US4966898A (en) 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
JPH06507355A (ja) 1991-03-01 1994-08-25 エレクトロスタティック　テクノロジー　インコーポレーテッド 回路板用薄層板等を製造するための粉体コーティング法
US5457102A (en) * 1994-07-07 1995-10-10 Janssen Pharmaceutica, N.V. Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
CA2127689A1 (en) * 1992-01-27 1993-08-05 Marcel A. C. Janssen Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
GB2265624B (en) 1992-03-31 1995-04-19 British Tech Group 17-substituted steroids useful in cancer treatment
GB9310635D0 (en) 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
CN1131944A (zh) 1993-09-30 1996-09-25 山之内制药株式会社 唑类衍生物和它的药物组合物
WO1996014090A1 (en) 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
WO1997000257A1 (en) 1995-06-14 1997-01-03 Yamanouchi Pharmaceutical Co., Ltd. Fused imidazole derivatives and medicinal composition thereof
EP0974584B1 (de) 1997-02-21 2003-01-15 Takeda Chemical Industries, Ltd. Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
ATE264304T1 (de) 1997-10-02 2004-04-15 Daiichi Seiyaku Co Dihydronaphthalinderivate und verfahren zur herstellung derselben
ATE293102T1 (de) 1998-04-23 2005-04-15 Takeda Pharmaceutical Naphthalene derivate ,ihre herstellung und verwendung
PE20010781A1 (es) * 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion

Also Published As

Publication number Publication date
DE60119963D1 (de) 2006-06-29
DE60119963T2 (de) 2006-10-05
MY134929A (en) 2008-01-31
EP1334106B1 (de) 2006-05-24
KR100809899B1 (ko) 2008-03-10
IL155624A0 (en) 2003-11-23
PT1334106E (pt) 2006-08-31
EP1681290A2 (de) 2006-07-19
SI1334106T1 (sl) 2006-10-31
NZ526387A (en) 2004-02-27
WO2002040484A2 (en) 2002-05-23
CY1105423T1 (el) 2010-04-28
EP1681290A3 (de) 2006-07-26
CN100572363C (zh) 2009-12-23
CN1329394C (zh) 2007-08-01
JP2003201282A (ja) 2003-07-18
KR20050105287A (ko) 2005-11-03
BR0115306B1 (pt) 2013-12-24
DK1334106T3 (da) 2006-09-18
WO2002040484A3 (en) 2002-09-26
BR0115306A (pt) 2004-02-10
TWI306099B (en) 2009-02-11
ATE327237T1 (de) 2006-06-15
US7141598B2 (en) 2006-11-28
NO326366B1 (no) 2008-11-17
AU2005225035B2 (en) 2007-02-22
CN1474819A (zh) 2004-02-11
HUP0400549A3 (en) 2004-09-28
JP2006045239A (ja) 2006-02-16
EP1681290B9 (de) 2013-06-19
AR034854A1 (es) 2004-03-24
NO20032234D0 (no) 2003-05-16
MXPA03004347A (es) 2004-05-04
HU229408B1 (hu) 2013-12-30
EP1334106A2 (de) 2003-08-13
CN1900079A (zh) 2007-01-24
PL362766A1 (en) 2004-11-02
CA2429133C (en) 2009-08-18
EP1681290B1 (de) 2011-11-16
NO20032234L (no) 2003-07-16
AU2002214296B2 (en) 2005-09-29
PL204934B1 (pl) 2010-02-26
KR20030048156A (ko) 2003-06-18
CN1680336A (zh) 2005-10-12
AU2005225035A1 (en) 2005-11-10
CA2429133A1 (en) 2002-05-23
AU1429602A (en) 2002-05-27
AU2002214296C1 (en) 2006-04-13
IL155624A (en) 2006-12-31
KR100725442B1 (ko) 2007-06-07
PE20020596A1 (es) 2002-08-13
JP3753971B2 (ja) 2006-03-08
HK1056168A1 (en) 2004-02-06
JP4427496B2 (ja) 2010-03-10
HUP0400549A2 (hu) 2004-06-28
ES2260303T3 (es) 2006-11-01
US20040033935A1 (en) 2004-02-19
KR20080002929A (ko) 2008-01-04

Similar Documents

Publication Publication Date Title
ATE286021T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
DE10084441T1 (de) Koalinton-Pigmente, ihre Herstellung und Verwendung
DE60107859D1 (de) Benzimidazolderivate, ihre herstellung und therapeutische verwendung
ATE539062T1 (de) Bizyklishe verbindung, ihre herstellung und verwendung
DE60008862D1 (de) Thienopyrimidin verbindungen, ihre herstellung und verwendung
DE69916828D1 (de) Pyrazoline, ihre herstellung und verwendung als medikamente
DE60038200D1 (de) ren Herstellung und Verwendung
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
DE10084442T1 (de) Kaolin-Pigmente, ihre Herstellung und Verwendung
DE60123210D1 (de) Picolinsäure-derivate und ihre verwendung als fungizide
DE50207849D1 (de) Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung
ATE272634T1 (de) Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung
DE60001307D1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
ATE332294T1 (de) Dihydro-1,3,5-triazin-diamin-derivate und ihre therapeutische verwendung
DE60235547D1 (de) En daraus, deren herstellung und verwendung
DE60103394D1 (de) 4-(2-phenylthiazol-5-yl)1,4-diazabicyclo[3.2.2]nonanederivate, ihre herstellung und therapeutische verwendung
DE59901120D1 (de) Kationische rutheniumkomplexe, ihre herstellung und ihre verwendung
DE59802590D1 (de) Cyclische Cedren-Acetale, ihre Herstellung und ihre Verwendung
ATE327237T1 (de) Imidazol derivate, ihre herstellung und ihre verwendung
ATE265454T1 (de) Phenyloxazol-1,4-diazabicyclo(3.2.2)nonanderiva e,ihre herstellung und ihre therapeutische verwendung
DE60009155D1 (de) Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
DE60321372D1 (de) 3-phenylpyridoindolderivate, ihre herstellung und verwendung
DE60006958T2 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
ATE251170T1 (de) Titanverbindungen, deren herstellung und verwendung